BRD-K16295392-003-01-3
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A002 HELA 24H D21 atrasentan 1.11um.tsv.gz
uterine cervix
Label
Description
A Substance
A 160 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project